Erythropoietin Dose and Mortality in Hemodialysis Patients: Marginal Structural Model to Examine Causality

It has been previously reported that a higher erythropoiesis stimulating agent (ESA) dose in hemodialysis patients is associated with adverse outcomes including mortality; however the causal relationship between ESA and mortality is still hotly debated. We hypothesize ESA dose indeed exhibits a dire...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Nephrol
Autori principali: Streja, Elani, Park, Jongha, Chan, Ting-Yan, Lee, Janet, Soohoo, Melissa, Rhee, Connie M., Arah, Onyebuchi A., Kalantar-Zadeh, Kamyar
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi Publishing Corporation 2016
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4889858/
https://ncbi.nlm.nih.gov/pubmed/27298736
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/6087134
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi